NODE-NEGATIVE BREAST CANCER
Clinical trials for NODE-NEGATIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new NODE-NEGATIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for NODE-NEGATIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a 6-Month hormone pill spare women from mastectomy?
Disease control OngoingThis study tests whether giving hormone therapy for 6 months before surgery can help remove all cancer in one piece, reducing the need for a full mastectomy. It includes 8 postmenopausal women with early-stage, low-risk, ER-positive breast cancer. The main goal is to see if the t…
Matched conditions: NODE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Irada Ibrahim-zada • Aim: Disease control
Last updated May 17, 2026 04:15 UTC
-
New combo therapy aims to keep breast cancer from coming back
Disease control OngoingThis study tests whether a combination of two targeted drugs (trastuzumab and pertuzumab) plus hormone therapy can prevent breast cancer from returning after surgery. It includes about 393 people with early-stage, hormone receptor-positive, HER2-positive breast cancer that has no…
Matched conditions: NODE-NEGATIVE BREAST CANCER
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 17, 2026 04:15 UTC